19 Aug 2024
// PRESS RELEASE
14 Aug 2024
// GLOBENEWSWIRE
16 Apr 2024
// PRESS RELEASE
Digital content
CORPORATE CONTENT #SupplierSpotlight
19 Aug 2024
// PRESS RELEASE
https://www.everpharma.com/news/ever-pharma-gained-eu-approval-of-testosterone-enantate/
14 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/14/2930389/0/en/Silo-Pharma-Expands-Development-Agreement-with-Sever-Pharma-for-Novel-Ketamine-Implant-Therapeutic.html
16 Apr 2024
// PRESS RELEASE
https://www.everpharma.com/news/ever-pharma-gained-eu-approval-for-advanced-cancer-treatment/
13 Mar 2024
// PRESS RELEASE
https://www.everpharma.com/news/ever-pharma-announces-approval-of-testosterone-undecanoate-in-the-eu/
22 Jun 2023
// PRESS RELEASE
https://www.everpharma.com/news/ever-pharma-gains-eu-marketing-authorization-for-trabectedin/
10 Mar 2023
// PRESS RELEASE
https://www.everpharma.com/news/ever-pharma-expands-operations-with-opening-of-new-manufacturing-facility-in-jena-germany/
LOOKING FOR A SUPPLIER?